Airtel
offers 'M Business 'suite of solutions for cos
Mumbai: Bharti Tele-Ventures has entered the
mobile business solutions market with its 'M-Business'
suite of solutions through its cellular services arm Airtel.
The
company plans to offer customised telecom solutions integrating
wireless, wireline and data services to businesses.
The company says the 'M-Business' suite of solutions will
enable corporates to reduce telecommunication costs by
20-25 percent.
Company officials said the size of the mobile business
solutions market for the cellular segment alone has been
estimated at over Rs 1,000 crore, which makes it an attractive
business to enter.
The company has split its target customer base into two
segments large businesses and small and medium
enterprises (SME).
The industry verticals, being targeted by the company
include IT services firms, call centres, manufacturing
and engineering companies and banking and financial services.
Back
to News Review index page
GM
India writes off losses worth Rs 373 crore
New Delhi: General Motors India, the wholly owned
subsidiary of General Motors Corporation has accumulated
losses worth Rs 400.4 crore in the accounting period ended
September 30, '02.
According
to the company's profit and loss account for April 1,
2001-September 30, 2002 a large chunk of the losses
Rs 373.4 crore has been written off against the
company's share value, bringing it down from Rs 10 to
Rs 4.25/share.
The
company says this was done to represent the worth of the
share considering losses accumulated during the initial
years of operations.
The
company is hopeful of making good its losses with the
launch of mainstream cars like Corsa sail and Optra and
says in future these type of write-offs will not be required.
Back
to News Review index page
MphasiS-BFL
Q1 net up 40.3 percent
Bangalore: Software and BPO services group, Mphasis-BFL's
net profit jumped 40.3 per cent to Rs 19.49 crore in the
April-June quarter of the current fiscal from Rs 13.879
crore last year.
Sequentially, net profit rose by 4.1 per cent. The revenue
for the group grew 45 per cent to Rs 130.22 crore year
on year and 7.7 per cent over last quarter.
Mphasis'
hike in revenues came from development of e-solutions
for onsite engagements as well as offshore efforts from
new and exiting clients and also call-centre subsidiary
MsourcE, said the company.
MsourcE
won two new clients in the last quarter and MphasiS added
10 new customers, of which five were in the financial
services vertical.
Back
to News Review index page
Lupin to sell
12.5 percent stake to Newbridge
Mumbai: The promoter of pharma major Lupin Ltd,
Dr Desh Bandhu Gupta, has announced his intention to sell
nearly five million shares amounting to 12.55 per cent
of Lupin's equity at Rs 252 per share to Newbridge Capital
for a total consideration of Rs 127 crore. This comes
after a placement with Citigroup.
Henceforth the stake of the promoters and associates in
Lupin Ltd will fall to 42 per cent.
Last
week, Dr Gupta had sold 12.55 per cent to CVC International,
a Citigroup company for a consideration of Rs 126 crore.
According
to a release by the company, the purchase by Newbridge
is conditional upon various matters including approvals
by the board of directors of Lupin and the investment
committee of Newbridge Capital, completion of a due diligence
process, receipt of regulatory approvals and execution
of the final detailed agreements. The
process will be completed in the next two months.
Back
to News Review index page
Timex
to set off losses against net worth
Timex Watches Ltd has proposed to set off its losses against
its net worth. The proposal was cleared at the company's
board meeting held yesterday.
The
company has accumulated losses of Rs 125 crore during
the 12 years of its operations in India. Its gross net
worth as on March 31, 2003, was Rs 143.87 crore.
As
per the proposal, Timex Watches will reduce the paid-up
capital value per equity share from Rs 10 to Re 1 as well
as the paid-up value of preference share capital from
Rs 100 a share to Rs 10. The company will also utilise
the amount available in the share premium account.
Timex
of the US holds 83.54 per cent of its equity capital and
100 per cent of the preference share capital.
Timex
will now have to get the approval of the minority shareholders
in its coming annual general meeting and will also have
to apply to the regulatory authorities and the Delhi High
Court before implementing the scheme.
Back
to News Review index page
ACC
earmarks Rs 275 crore for capex
Mumbai: The 16.4 million tonne cement major, Associated
Cement Companies (ACC), has earmarked Rs 275 crore for
capex in the current fiscal.
The
investment would primarily be spent on modernisation of
the existing plants and technology upgradation of some
facilities.
The company is planning to setup two new ready mix cement
(RMC) units, one at Noida and the other in Mumbai during
the current year. The company currently operates 11 RMC
units across the country.
Meanwhile
the company is exploring the option of a brownfield expansion
at its Chibasa unit at Jharkhand.
Back
to News Review index page
UTStarcom
plans manufacturing unit in India
New
Delhi: US telecom company UTStarcom plans to set up
manufacturing operations in India and has applied to the
foreign investment promotion board (FIPB) for setting
up a subsidiary.
The company's plans are in initial stages.
Sources
said the company has not yet decided whether to go for
domestic manufacturing with a partner or on its own.
The
company already has R&D centres in India. It has over
160 employees in its various offices in India.
UTStarcom
is world leader in PHS, a wireless access technology.
It is also one of the largest suppliers of broadband systems.
Recently, it launched its MediaSwitch, an end-to-end solution
designed for telecom operators and broadband service providers
to deliver high quality TV and on-demand entertainment
service over IP.
Back
to News Review index page
Reddy's
obtains tentative US FDA approval nod for drug
Hyderabad: Dr Reddy's Laboratories has received
tentative approval from the US Food and Drugs Administration
for Nesazodine HCL tablets with dosage strengths of 50
mg, 100 mg, 150 mg, 200 mg and 250 mg.
Nesazodine
is the generic variant anti-depressant drug Serzone.
Seven other companies have also received tentative approvals
for the drug which recorded a sales of $261 million in
the US in 2002 as per IMS data.
The
product is not likely to contribute any major revenues
for the company in view of the presence of several players
and a limited market size.
Back
to News Review index page
CCD
meet to consider CMC, VSNL residual stake sale
The meeting of the Cabinet Committee on Disinvestment
(CCD) on July 10 will consider sale of 26 per cent residual
government equity each in Videsh Sanchar Nigam Ltd (VSNL)
and CMC Ltd.
Officials said the government enthused by the Maruti IPO,
was exploring options of book-building to offload its
residual stake, provided the strategic partners agreed
to it. However, the Tatas have remained non-committal
so far.
The
Tatas hold 65 per cent stake in CMC, and as per the shareholders'
agreement, have the first right of refusal to buy the
residual government equity in the company.
According
to the agreement the group can either buy the stake at
Rs 197 a share (the price at which the stake was acquired
from the government) or at the fair market price, whichever
is higher. The CMC stock is currently ruling at Rs 435.
For
VSNL, the Tatas had launched an open offer after acquiring
26 per cent stake in the company from the government.
They picked up almost 24 per cent stake through the offer,
and their stake is now at around 50 per cent.
The
CCD meeting will also take up the cases of Hindustan Copper
Ltd (HCL), Mineral Exploration Corporation Ltd (MECL),
Dredging Corporation of India Ltd (DCIL), Hindustan Organics
and Chemicals Ltd (HOCL) and National Fertiliser Ltd (NFL).
Back
to News Review index page
|